Q4 2025 Earnings Call Transcript February 26, 2026Amphastar Pharmaceuticals, Inc. misses on earnings expectations.

(PFI), the inventors of Photonic Soldering technology, today announced a major breakthrough enabling high-temperature solder alloy reflow in ambient atmosphere without the use of active flux. This ...

InstantGMP INV adds enhanced five-layer bin location tracking, plus serial numbers and scheduler updates for GMP, ...

Full Year 2025 Performance Met or Exceeded All Guidance Metrics and 2026 Reflects Another Year of Growth –‒ Q42025 Net Revenue of $814 million; ...

A blockbuster drug is a best-selling medication earning over $1 billion annually. Learn about them and how they revolutionize ...

Indivior Pharmaceuticals, Inc. ( INDV) Q4 2025 Earnings Call February 26, 2026 8:00 AM EST Good morning, everyone. I am joined today by Joe Ciaffoni, Chief Executive Officer; Pat Barry, Chief ...

GoodRx projects Pharma Direct revenue to grow at least 30% year-over-year in 2026. Management anticipates continued acceleration in condition-specific subscriptions launched in late 2025, with weight ...

Record GAAP and non-GAAP operating profit for full year 2025— —Maintained full year 2026 ORLADEYO revenue guidance between $625 and $645 million— —Received FDA approval for ORLADEYO oral pellets for p ...

Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three and twelve months ended ...

Hikma Pharmaceuticals Plc (LON:HIK) on Thursday posted full-year results in line with guidance but warned of a sharp drop in ...

Aurobindo Pharma added 1.61% to Rs 1,233.55 after the company announced that its wholly owned subsidiary, Eugia Pharma Specialities, has received final approval from the US Food & Drug Administration ...